Yahoo
Argus

Argus

Apr 15, 2026

ACAD: What does Argus have to say about ACAD?

Symbols

ACAD

Sector(s)

Healthcare

Rating

Earnings Estimate

Current Price

$21.95

Price Target

Summary

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in cen

Upgrade to begin using premium research reports and get so much more.

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Upgrade
Mobilize your Website
View Site in Mobile | Classic
Share by: